A man’s failure to sustain an erection that is adequate enough for sexual
activity is known as erectile dysfunction. It also refers to the inconsistency
to do so, or the inability to endure it for an extended period. Erectile
dysfunction can be due to a number of reasons including aging, high blood
pressure, diabetes mellitus, depression, smoking, nerve or spinal cord damage,
alcoholism, and low testosterone levels. Treatments for erectile dysfunction
include adopting a healthy lifestyle, oral phosphodiesterase type 5 (PDE5) inhibitors,
vacuum devices, and surgery. Erectile dysfunction affects the quality of life
and leads to stress, anxiety, and self-confidence problems. New research is
undergoing in the field of erectile dysfunction to find more enhanced and
effective therapies.
Analysts forecast the Global Erectile
Dysfunction Drugs market to decline at a
CAGR of 4.47 percent over the period 2013-2018.
The Report recognizes the following companies as the key players in the
Global Erectile Dysfunction Drugs Market: Apricus Biosciences Inc., Bayer AG,
Dong-A Socio Holdings Co. Ltd., Eli Lily & Co., Pfizer Inc. and Vivus Inc.
Other Prominent Vendors in the market are: Auxillium Pharmaceuticals,
Cristalia Produtos Quimicos Farmaceuticos, Futura Medical, Johnson &
Johnson, Meda Pharmaceuticals, Pacific Therapeutics and Seattle Genetics.
One of the emerging trends in this market is an increase in awareness of
erectile dysfunction. The acceptability of erectile dysfunction drugs is
expected to increase owing to increasing public awareness about erectile dysfunction
and the need to treat it.
Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=23077 .
Covered in this
Report
This report covers the present scenario and the growth prospects of the
Global Erectile Dysfunction Drugs market for the period 2014-2018. The Global
Erectile Dysfunction Drugs market can be divided into six segments: PDE 5
Inhibitors, Vacuum Constriction Device, Penile Prosthesis, Vascular
Reconstructive Surgery, Injection Therapies, and Testosterone Replacement
Therapy. To calculate the market size, the report considers the revenue
generated from the sales of various drugs and topical creams used for the
treatment of erectile dysfunction.
Global Erectile Dysfunction Drugs Market 2014-2018, has been prepared
based on an in-depth market analysis with inputs from industry experts. The
report covers the Americas, and the APAC and EMEA regions; it also covers the
Global Erectile Dysfunction Drugs market landscape and its growth prospects in
the coming years. The report includes a discussion of the key vendors operating
in this market.
According to the report, one of the main drivers in the market is the
increase in aging population. The number of patients suffering from erectile
dysfunction is growing owing to increasing aging population both in developing
and developed countries.
Further, the report states that one of the main challenges in the market
is the high cost of erectile dysfunction drugs. Despite numerous benefits, the
high cost of erectile dysfunction drugs hinders acceptability among patients.
Many patients do not have the required budget for investing in high-cost
treatment options.
Single User License of the Report is Available
at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=23077 .
